OrbiMed Capital GP IV LLC, Director, 10% Owner at Anthera Pharmaceuticals Inc (ANTH), sold 39,000 shares at $8.53 ($333K) on 2011-05-26, disclosed to the SEC on 2011-05-27.
Open-market sale of $333k ANTH by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.65 | 4,800 | $42K | 12.5% |
| 2 | $8.53 | 34,200 | $292K | 87.5% |
| Total | $8.54 avg | 39,000 | $333K | 100% |
| Filing → |
| BOLD | SELL | 2018-03-12 | $10.2M | — | Filing → |
| BOLD | SELL | 2017-09-11 | $112K | — | Filing → |
| OTIC | SELL | 2015-11-24 | $5.7M | — | Filing → |